Chylous effusions are a well-described complication of lymphangioleiomyomatosis (LAM) in both pre- and post-transplant patients. Chylous effusions can cause significant morbidity among patients and most treatment modalities have limitations to complete success. We describe the use of a pleurovenous shunt to treat a refractory chylous effusion in a patient after lung transplant for LAM. After shunt placement, the patient had complete resolution of the chylous effusion and subsequent discharge home after a prolonged hospitalization. The use of a pleurovenous shunt for refractory chylous effusions is a viable option after conventional therapy fails.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healun.2007.07.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pleurovenous Shunt Placement for the Management of Nonmalignant Pleural Effusion.
Semin Intervent Radiol
June 2022
Division of Interventional Radiology, University of California San Diego School of Medicine, San Diego, California.
Therapeutic thoracentesis is a first-line therapy in the management of patients with medically refractory, nonmalignant pleural effusion. However, when required in short intervals, serial thoracenteses can lead to increased procedure-related complications and negatively impact quality of life. Alternative treatment options vary depending on the etiology of fluid accumulation.
View Article and Find Full Text PDFDisseminated Cryptococcal Disease in A Patient With Chronic Chylothorax and a Pleurovenous Catheter, a Case Report With Autopsy Findings.
Open Forum Infect Dis
June 2021
Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
species are ubiquitous in the environment with a global distribution. While causing disease predominantly in immunocompromised hosts such as those with advanced HIV, HIV-uninfected patients are increasingly recognized as being affected. The most common forms of infection are cryptococcal pneumonia and meningitis.
View Article and Find Full Text PDFGeneralized lymphatic anomaly (GLA) and Gorham-Stout disease (GSD) are related diseases involving the lymphatic vasculature. Patients with these diseases frequently develop chylothorax, which can cause respiratory distress, failure, and death. Unfortunately, the optimum treatment for GLA and GSD patients with chylothorax remains unknown.
View Article and Find Full Text PDFThe changing management of chylothorax in the modern era.
Eur J Cardiothorac Surg
January 2016
Saint George's University School of Medicine, Grenada Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA Department of Surgery, Rutgers University, New Jersey Medical School, Newark, NJ, USA
Initial conservative therapy is applied to all cases of chylothorax (CTx) with expected excellent outcomes. The indication for aggressive surgical treatment of early CTx remains uncertain and requires rigorous scientific scrutiny. Lymphangiography and lymphoscintigraphy are useful to localize the leak and assess thoracic duct patency as well as to differentiate partial from complete thoracic duct transection.
View Article and Find Full Text PDFA staged management of prolonged chylothorax in a patient with yellow nail syndrome.
BMJ Case Rep
November 2012
Department of Thoracic Surgery, Norfolk and Norwich University Hospital, UK.
Spontaneous chylothorax remains an unusual condition with diverse aetiologies and non-unified management strategies. Owing to the rarity of the condition, the evidence of management remains from case reports and limited retrospective studies. This case represents a difficult-to-manage chylothorax secondary to yellow nail syndrome with initial failure of both surgical and conservative treatment methods.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!